KANSAS CITY, Mo., June 8, 2023 /PRNewswire/ — Liquid Mobile, formerly Liquid Mobile IV, is revolutionizing access to health and wellness by expanding offerings and changing its name to better represent a commitment to providing groundbreaking access to whole-body wellness. The Kansas-City based company is launching new services straight to consumers’ doorsteps in June 2023, … Read more
KT430 is a preclinical, next-generation investigational gene therapy to treat X-linked myotubular myopathy (XLMTM) TOKYO and SAN DIEGO, June 8, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”), and Kate Therapeutics (“KateTx”) today announced an exclusive license agreement to develop and commercialize KT430. KT430 is a preclinical next-generation investigational … Read more
Series A financing co-led by Westlake Village BioPartners and Versant Ventures Company advancing systemically delivered, skeletal and cardiac muscle targeted, liver de-targeted capsid and cargo technology platforms Initial pipeline addressing myotonic dystrophy type 1 and facioscapulohumeral muscular dystrophy Company grants Astellas Pharma Inc. exclusive license to KT430 to treat X-linked myotubular myopathy SAN DIEGO, June … Read more
JINAN, China, June 8, 2023 /PRNewswire/ — Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023). Study One:Title: DUBHE-L-304: A randomized, double-blind, multicenter … Read more
VADUZ, Liechtenstein, June 8, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that the world-renowned anti-reflux surgeon, Professor Luigi Bonavina from IRCCS Policlinico San Donato Hospital in Milan, Italy completed his first two RefluxStop™ procedures recently. Professor Bonavina is the Head of the University … Read more
CARLSBAD, Calif., June 7, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today the pricing of $500.0 million aggregate principal amount of 1.75% Convertible Senior Notes due 2028 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities … Read more
NEW YORK, June 8, 2023 /PRNewswire/ — The ambulatory cardiac monitoring devices market is set to grow by USD 2,091.31 million from 2022 to 2027 progressing at a CAGR of 6.28% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The rising … Read more
Über drei Jahrzehnte Erfahrung in den Bereichen Vertrieb, Marketing, Regulierung und Betrieb Erfahrung bei der Bildung funktionsübergreifender Teams und beim Aufbau von Verkaufs- und Vertriebsnetzwerken MUMBAI, Indien, 8. Juni 2023 /PRNewswire/ — Piramal Pharma Limiteds (NSE: PPLPHARMA) (BSE: 543635) Piramal Critical Care (PCC), ein Hersteller von Inhaled Anesthetics und Global Player im Bereich der Krankenhausgenerika, hat … Read more
Plus de trois décennies d’expérience dans les domaines de la vente, du marketing, de la réglementation et de l’exploitation Expertise en création d’équipes interfonctionnelles et en création de réseaux de vente et de distribution MUMBAI, Inde, 8 juin 2023 /PRNewswire/ — La division commerciale Piramal Critical Care (PCC) de Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: … Read more
STOCKHOLM, June 8, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has submitted a marketing authorization application for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain, to the Ministry of … Read more